Xilio Therapeutics, Inc. (XLO)
9.05
+0.04
(+0.44%)
USD |
NASDAQ |
Oct 09, 16:00
9.08
+0.03
(+0.33%)
After-Hours: 20:00
Xilio Therapeutics Market Cap : 59.55M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 59.55M |
| October 08, 2026 | 59.29M |
| October 07, 2026 | 59.29M |
| October 06, 2026 | 59.22M |
| October 05, 2026 | 59.94M |
| October 02, 2026 | 59.29M |
| October 01, 2026 | 58.63M |
| September 30, 2026 | 59.55M |
| September 29, 2026 | 58.81M |
| September 28, 2026 | 59.55M |
| September 25, 2026 | 59.48M |
| September 24, 2026 | 59.22M |
| September 23, 2026 | 58.83M |
| September 22, 2026 | 59.48M |
| September 21, 2026 | 59.35M |
| September 18, 2026 | 60.08M |
| September 17, 2026 | 59.48M |
| September 16, 2026 | 59.09M |
| September 15, 2026 | 59.42M |
| September 14, 2026 | 58.76M |
| September 11, 2026 | 58.76M |
| September 10, 2026 | 58.76M |
| September 09, 2026 | 59.02M |
| September 08, 2026 | 58.63M |
| September 04, 2026 | 59.22M |
| Date | Value |
|---|---|
| September 03, 2026 | 59.35M |
| September 02, 2026 | 58.17M |
| September 01, 2026 | 58.43M |
| August 31, 2026 | 58.89M |
| August 28, 2026 | 59.22M |
| August 27, 2026 | 59.29M |
| August 26, 2026 | 59.55M |
| August 25, 2026 | 59.75M |
| August 24, 2026 | 60.47M |
| August 21, 2026 | 60.73M |
| August 20, 2026 | 60.73M |
| August 19, 2026 | 61.92M |
| August 18, 2026 | 62.51M |
| August 17, 2026 | 62.45M |
| August 14, 2026 | 60.34M |
| August 13, 2026 | 59.29M |
| August 12, 2026 | 59.55M |
| August 11, 2026 | 60.41M |
| August 10, 2026 | 60.54M |
| August 07, 2026 | 60.34M |
| August 06, 2026 | 53.60M |
| August 05, 2026 | 52.68M |
| August 04, 2026 | 52.56M |
| August 03, 2026 | 52.33M |
| July 31, 2026 | 52.68M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cue Biopharma, Inc. | 144.65M |
| ACADIA Pharmaceuticals, Inc. | 3.405B |
| Alnylam Pharmaceuticals, Inc. | 31.12B |
| Anika Therapeutics, Inc. | 262.04M |
| Savara, Inc. | 1.011B |
Market Cap Related Metrics
| PS Ratio | 2.078 |
| Price to Book Value | 0.8241 |
| Price | 9.05 |
| Earnings Yield | -18.63% |